In conclusion, the adaptive immune response plays complex roles in NASH-related hepatocarcinogenesis, with current research directing attention to the mechanisms of CD8+ T cells and Th17 cells. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.